Halozyme Therapeutics shares owned by Caxton Associates
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Caxton Associates
from 13F filings
Historical chart of Caxton Associates investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Caxton Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $306k | 8.3k | 36.96 |
| 2023-03-31 | $498k | 13k | 38.19 |
| 2022-06-30 | $430k | 9.8k | 43.96 |
| 2020-12-31 | $447k | 11k | 42.69 |
| 2020-06-30 | $1.3M | 49k | 26.80 |
| 2019-12-31 | $574k | 32k | 17.74 |